Laboratory Research Tool

About Truly Technologies

Truly Technologies is a University of Washington spinout founded in 2021, focusing on a novel osmotic bioprocessing platform. The company's passive, power-free device concentrates and purifies biomolecules like diagnostic biomarkers and therapeutic nanoparticles with high yield and purity, addressing key bottlenecks in sample preparation. Targeting the digital health and AI/machine learning sectors, Truly aims to enable more sensitive diagnostics and efficient biomanufacturing through its versatile and scalable technology. The company is in an early, pre-revenue stage, building partnerships and validating its platform across multiple applications.